Arax Advisory Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Arax Advisory Partners’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$925K	Buy	+16,270	New	+$776K	0.01%	1256

Other funds holding GNOM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

WMP

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

Arax Advisory Partners's GNOM Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 16,270 shares worth $925K. The stake represents 0.01% of the portfolio and ranks #1256 among its holdings.

36 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Arax Advisory Partners held 16,270 shares of Global X Genomics & Biotechnology ETF worth $925K as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new Arax Advisory Partners position in Q2 2026.
Global X Genomics & Biotechnology ETF made up 0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1256 holding.
36 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.